Your browser doesn't support javascript.
loading
The immunoglobulin M-degrading enzyme of Streptococcus suis, IdeSsuis, is a highly protective antigen against serotype 2.
Seele, Jana; Hillermann, Lena-Maria; Beineke, Andreas; Seitz, Maren; von Pawel-Rammingen, Ulrich; Valentin-Weigand, Peter; Baums, Christoph G.
Afiliación
  • Seele J; Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Hillermann LM; Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Beineke A; Department of Pathology, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Seitz M; Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.
  • von Pawel-Rammingen U; Department of Molecular Biology and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
  • Valentin-Weigand P; Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Baums CG; Institute for Microbiology, Department of Infectious Diseases, University of Veterinary Medicine Hannover, Hannover, Germany; Institute for Bacteriology and Mycology, Centre of Infectious Diseases, College of Veterinary Medicine, University Leipzig, Leipzig, Germany. Electronic address: christoph.ba
Vaccine ; 33(19): 2207-2212, 2015 May 05.
Article en En | MEDLINE | ID: mdl-25825330
Streptococcus suis (S. suis) is a major porcine pathogen causing meningitis, arthritis and several other pathologies. Recently, we identified a highly specific immunoglobulin M degrading enzyme of S. suis, designated IdeSsuis, which is expressed by various serotypes. The objective of this work was to access the immunogenicity and protective efficacy of a recombinant vaccine including IdeSsuis. Vaccination with rIdeSsuis elicited antibodies efficiently neutralizing the IgM protease activity. Importantly, 18 piglets vaccinated with rIdeSsuis alone or in combination with bacterin priming were completely protected against mortality and severe morbidity after S. suis serotype 2 challenge. In contrast, 12 of the 17 piglets either treated with the placebo or primed with the bacterin only, succumbed to S. suis disease. Immunity against IdeSsuis was associated with increased killing of S. suis wt in porcine blood ex vivo leading to a tenfold difference in the bacterial survival factor in blood of placebo-treated and rIdeSsuis-vaccinated piglets. In conclusion, the results of this study indicate that rIdeSsuis is a highly protective antigen in pigs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Infecciones Estreptocócicas / Enfermedades de los Porcinos / Vacunas Bacterianas / Streptococcus suis / Antígenos Bacterianos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Infecciones Estreptocócicas / Enfermedades de los Porcinos / Vacunas Bacterianas / Streptococcus suis / Antígenos Bacterianos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Países Bajos